Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials (Q33767211)

29 July 2017

0 references

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials (English)

1 reference

29 July 2017

1 reference

1 reference

3

Jill F F Belch

1 reference

29 July 2017

2

F Gerald R Fowkes

1 reference

29 July 2017

Peter M Rothwell

1

1 reference

29 July 2017

Hisao Ogawa

series ordinal

4

1 reference

29 July 2017

Charles P Warlow

series ordinal

5

1 reference

29 July 2017

Tom W Meade

series ordinal

6

1 reference

29 July 2017

language of work or name

English

0 references

publication date

6 December 2010

1 reference

29 July 2017

1 reference

29 July 2017

volume

377

1 reference

29 July 2017

issue

9759

1 reference

29 July 2017

page(s)

31-41

1 reference

Global patterns of cancer incidence and mortality rates and trends

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)62110-1

7 January 2021

Estimates of the cancer incidence and mortality in Europe in 2006.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)62110-1

7 January 2021

Preventable cancer in the USA

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)62110-1

7 January 2021

Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)62110-1

7 January 2021

Aspirin, salicylates, and cancer.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)62110-1

7 January 2021

Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)62110-1

7 January 2021

Aspirin and cancer risk: a summary review to 2007.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)62110-1

7 January 2021

Long term hormone therapy for perimenopausal and postmenopausal women

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)62110-1

7 January 2021

Those confounded vitamins: what can we learn from the differences between observational versus randomised trial evidence?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)62110-1

7 January 2021

Excess of Solid Cancers After Prasugrel: The Food and Drug Administration Outlook

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)62110-1

7 January 2021

Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)62110-1

7 January 2021

Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)62110-1

7 January 2021

Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)62110-1

7 January 2021

Aspirin and the risk of colorectal cancer in relation to the expression of COX-2.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)62110-1

7 January 2021

Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)62110-1

7 January 2021

The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)62110-1

7 January 2021

Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report 14. ETDRS Investigators

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)62110-1

7 January 2021

Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)62110-1

7 January 2021

The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)62110-1

7 January 2021

Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)62110-1

7 January 2021

Reliability of cancer registration data in Scotland, 1997.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)62110-1

7 January 2021

Completeness of cancer and death follow-up obtained through the National Health Service Central Register for England and Wales

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)62110-1

7 January 2021

Reliability of data of the Thames cancer registry on 673 cases of colorectal cancer: effect of the registration process.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)62110-1

7 January 2021

Faecal occult blood screening for colorectal cancer at Nottingham: details of the verification process.

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)62110-1

7 January 2021

Death certificates provide an adequate source of cause of death information when evaluating lung cancer mortality: an example from the Mayo Lung Project

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)62110-1

7 January 2021

Colorectal Cancer Deaths as Determined by Expert Committee and from Death Certificate

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)62110-1

7 January 2021

Case-control study of use of nonsteroidal antiinflammatory drugs and glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)62110-1

7 January 2021

Aspirin and indomethacin exhibit antiproliferative effects and induce apoptosis in T98G human glioblastoma cells

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)62110-1

7 January 2021

Antiplatelet drug discontinuation is a risk factor for ischemic stroke

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)62110-1

7 January 2021

Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)62110-1

7 January 2021

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)62110-1

7 January 2021

Cost-effectiveness of aspirin treatment in the primary prevention of cardiovascular disease events in subgroups based on age, gender, and varying cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)62110-1

7 January 2021

Aspirin for the primary prevention of vascular events?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)62110-1

7 January 2021

A review of international pharmacoeconomic models assessing the use of aspirin in primary prevention

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)62110-1

7 January 2021

Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)62110-1

7 January 2021

Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)62110-1

7 January 2021

Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)62110-1

7 January 2021

Nitric oxide-donating aspirin derivatives suppress microsatellite instability in mismatch repair-deficient and hereditary nonpolyposis colorectal cancer cells

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)62110-1

7 January 2021

Aspirin suppresses the mutator phenotype associated with hereditary nonpolyposis colorectal cancer by genetic selection

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(10)62110-1

7 January 2021

10.1016/S0140-6736(10)62110-1

Identifiers

DOI

1 reference

29 July 2017

1 reference